Cohance Lifesciences Appoints Abhimanyu Ojha as CFO

Cohance Lifesciences Ltd announced the appointment of Mr. Abhimanyu Ojha as its new Chief Financial Officer (CFO) and Key Managerial Personnel, effective October 12, 2026. The decision was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Ojha brings over two decades of experience in finance leadership roles within multinational healthcare and pharmaceutical companies, including Intas Pharmaceuticals, Viatris, Sun Pharmaceuticals, and Ranbaxy Laboratories. His expertise spans financial strategy, business partnering, corporate governance, M&A, and operational excellence. The company also updated its authorized Key Managerial Personnel list for regulatory disclosures.